Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

9.830 +0.030 (+0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,145,571
Open 9.830
Bid (Size) 9.650 (10)
Ask (Size) 9.840 (2)
Prev. Close 9.800
Today's Range 9.785 - 9.930
52wk Range 9.200 - 14.63
Shares Outstanding 128,489,060
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr. 
Via Benzinga
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'
President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current... 
Via Benzinga
Topics Government

Performance

YTD
-23.8%
-23.8%
1 Month
+1.3%
+1.3%
3 Month
-7.9%
-7.9%
6 Month
-4.7%
-4.7%
1 Year
-10.9%
-10.9%

More News

Read More
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Via Benzinga
Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday
Via Stocktwits
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study
Via Benzinga
Dynavax (DVAX) Q2 Revenue Jumps 29%
Via The Motley Fool
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
From Deep Track Capital, LP
Via Business Wire
Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
From Deep Track Capital, LP
Via Business Wire
Deep Track Capital Comments on ISS Recommendation
From Deep Track Capital, LP
Via Business Wire
Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
From Deep Track Capital, LP
Via Business Wire
Breaking Down Dynavax Technologies: 5 Analysts Share Their Views
Via Benzinga
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Via Benzinga
Deep Track Capital Releases Investor Presentation on Dynavax Technologies
From Deep Track Capital, LP
Via Business Wire
Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
From Deep Track Capital, LP
Via Business Wire
Where Dynavax Technologies Stands With Analysts
Via Benzinga
Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
From Deep Track Capital, LP
Via Business Wire
Evaluating DYNAVAX TECHNOLOGIES CORP (NASDAQ:DVAX) using Mark Minervini’s winning stock formula
Via Chartmill
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
From Deep Track Capital, LP
Via Business Wire
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
From Deep Track Capital, LP
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15
Via Talk Markets
Topics Stocks / Equities

Frequently Asked Questions

Is Dynavax Technologies Corporation - Common Stock publicly traded?
Yes, Dynavax Technologies Corporation - Common Stock is publicly traded.
What exchange does Dynavax Technologies Corporation - Common Stock trade on?
Dynavax Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dynavax Technologies Corporation - Common Stock?
The ticker symbol for Dynavax Technologies Corporation - Common Stock is DVAX on the Nasdaq Stock Market
What is the current price of Dynavax Technologies Corporation - Common Stock?
The current price of Dynavax Technologies Corporation - Common Stock is 9.830
When was Dynavax Technologies Corporation - Common Stock last traded?
The last trade of Dynavax Technologies Corporation - Common Stock was at 10/17/25 04:00 PM ET
What is the market capitalization of Dynavax Technologies Corporation - Common Stock?
The market capitalization of Dynavax Technologies Corporation - Common Stock is 1.26B
How many shares of Dynavax Technologies Corporation - Common Stock are outstanding?
Dynavax Technologies Corporation - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.